Botulism Market Outlook
The botulism market is likely to expand its roots with a CAGR of 6.7% between 2022 and 2032. The market holds a size of US$ 7.32 Billion in 2022 while it is anticipated to reach a value of US$ 11.53 Billion by 2032.
Botulism Market Size (2022E)
US$ 7.32 Bn
Botulism Projected Size (2032F)
US$ 11.53 Bn
Value CAGR (2022-2032)
The rising cases of food and wound contamination are fueling the rising cases of botulism among people. Botulism is a serious illness caused by toxins along with wound infections. The bacteria behind the spread of the disease are known as clostridium botulism. The demand for more information about the disease, its symptoms, and its cure is fueling the growth of the botulism market.
Increased R&D programs funded by governments coupled with the strong efforts by CDC and WHO are pushing authorities to spread awareness around it. The botulism market is thriving due to these high-end research programs that deliver antitoxin for preventing the damage done by the bacteria.
The major factors that drive the growth of the botulism market include an increase in R&D practices, availability of efficient solutions for botulism, lack of hygiene in certain regions of the world, and increase in awareness about disease and treatments.
Different types of botulism involve food-borne botulism, infant botulism, wound botulism, latrogenic botulism, and adult intestinal toxemia botulism. The rising demand for botulism-specific antitoxins has fueled the demand for botulism treatment products.
Wound botulism, being the most common type, demands extra care as the wound needs to be healed along with detoxing the bacteria. While a damaged digestive system also triggers the chances of getting adult intestinal toxemia botulism. The geriatric population and the modern eating habits that revolve around packaged and canned food items are also the major driving factors for the botulism market.
Botulism is a rare but serious fatal paralytic disorder, caused by neurotoxins produced by a bacteria Clostridium botulinum. The symptoms of botulism are classified under foodborne botulism, wound botulism and infant botulism. some common symptoms include weakness, paralysis, vision,swallowing, breathing and speaking problems.
The weakness further leads to fatigue of limb muscles. The symptoms are not caused by the bacterium itself, but by the toxin produced by the bacterium. Children with less than 6 months of age are primarily attacked by this bacteria and may also occur to children with poor immune system.
The bacteria may enter the body through wounds, or by eating them from improperly canned or preserved food.
Patients who survive an episode of botulism poisoning may experience fatigue and shortness of breadth for years and long-term theray may be needed to aid recovery.
Major Factors that Drive the Growth of Botulism Market
There are many factors that directly cause botulism as an effect, such as contact with soil and dust in babies while a wound gets infected from the clostridium botulism bacteria as it gets introduced into the bloodstream.
The unknown eating factors that develop this bacterium and enter the human body can be explained as follows:
- Bottled garlic
- Canned tomatoes
- Carrot juice
- Foods kept warm or left unrefrigerated for too long
- Oils infused with herbs
- Potatoes baked in aluminum foil
- Canned cheese sauces
These unknown food habits can lead to the botulism while the treatment involves antitoxins that flushes out the toxins damaging your organs and skin. In some severe cases, doctors also prescribe hospitalization for months.
Botulism Market: Drivers and Restraints
The major factors that drives growth of botulism market includes, increase in R&D practices, availability of efficient solutions for botulism, lack of hygienity in certain region of the world and increase in the awareness about disease and treatments.
In addition, owing to strong efforts by WHO and CDC, the disease is getting irradiated slowly.However, high cost of R&D and government austerity are some of the hurdles expected to hinder the growth of botulism market.
Botulism Market: Overview
Botulism is generally treated with antitoxin and supportive care. Supportive care for botulism includes monitoring of respiratory function. Antitoxin is required in case of both foodborne and wound botulism. Wounds should be treated, usually surgically, to remove the source of the toxin-producing bacteria followd by administration of appropriate antibiotics.
Mechanical ventilators are needed when there is a breathing problem while rehabilitation therapies are needed in case of speaking or swallowing problem. Health care providersmust tell state health authorities or the U.S. Centers for Disease Control and Prevention (CDC) about patients with botulism, so that the contaminated food can be removed from stores.
Infants are more prone to unhygienic or contaminated food and hence, they are more prone to this disease.
Botulism Market: Region-wise Outlook
Region wise, the global botulism marketis classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa.The North American region is the most prominent market, followed by Europe. According to CDC, in the U.S., an average of 145 cases are reported each year. Of these, approximately 15% are foodborne, 65% are infant botulism and 20% are wound. However, Asia-Pacific region is the most promising market for the forecast period.
Botulism Market: Key Players
The major players operating in botulism market includes XOMA Corporation, AlphaVax, Inc., Microbiotix, Inc., Molecular Targeting Technologies, Inc., and Morphotek, Inc. amongst others.
The report covers exhaustive analysis on
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
- Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
- Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
- Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Botulism Market: Segmentation
Botulism market can be segmented based on product type, distribution channel and geography.
Based on drug type, botulism market can be segmented as follows:
- Trivalent Antitoxin
- Heptavalent Botulinium Antitoxin
Based on distribution channel, botulism market can be segmented as follows:
- Hospitals including hospital pharmacies
- Retail pharmacies